Alfa-carboline inhibitors of NPM-ALK, RET, and Bcr-Abl
US8895744B2 · kind B2 · utility
25Cited by
2References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 27, 2009 |
| Grant date | Nov 25, 2014 |
| Priority date | — |
| Expiry date | Jan 6, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula (I)
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.